Gamma-hydroxybutyrate and cocaine administration increases mRNA expression of dopamine D1 and D2 receptors in rat brain

Neuropsychopharmacology

Volumn 21, Issue 5, 1999, Pages 662-669

  Schmidt Mutter, Catherine ^a,c   Muller, Claude ^a   Zwiller, Jean ^b   Gobaille, Serge ^a   Maitre, Michel ^a  

^a LNMIC   (France)

^b CENTRE DE NEUROCHIMIE   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Cocaine; D1 and D2 dopamine receptors mRNA; GHB ( hydroxybutyrate); In situ hybridization; Rat brain

Indexed keywords

4 HYDROXYBUTYRIC ACID; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DRUG EFFECT; GENE EXPRESSION; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADJUVANTS, ANESTHESIA; ANIMALS; AUTORADIOGRAPHY; COCAINE; DOPAMINE UPTAKE INHIBITORS; FRONTAL LOBE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; NEOSTRIATUM; OLFACTORY PATHWAYS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SODIUM OXYBATE; SULFUR RADIOISOTOPES;

EID: 0032828615     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00066-4     Document Type: Article

References (36)

1. Ackerman J.M., White F.J. A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neurosci Lett. 117:1990;181-187.
2. Beardsley P.M., Balster R.L., Harris L.S. Evaluation of the discriminative stimulus and reinforcing effects of gamma-hydroxybutyrate (GHB). Psychopharmacology. 127:1996;315-322.
3. 3 receptor mRNA levels in rat brain following antipsychotic treatment. Psychopharmacology. 106:1992;479-483.
4. 2 dopamine receptor cDNA. Nature. 336:1988;783-787.
5. Chin M.Y., Kreutzer R.A., Dyer J.E. Acute poisoning from gamma-hydroxybutyrate in California. Western J Med. 156:1992;380-384.
6. Diana M., Pistis M., Carboni S., Gessa G.L., Rossetti Z.L. Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats. Electrophysiological and biochemical evidence Proc Natl Acad Sci USA. 90:1993;7966-7969.
7. Gallimberti L., Ferri M., Ferrara S.D., Fadda F., Gessa G.L. Gamma-hydroxybutyric acid for treatment of alcohol dependence. A double-blind study Alcohol Clin Expl Res. 16:1992;673-676.
8. Gallimberti L., Cibin M., Pagnin P., Sabbion R., Pani P.P., Piratsu R., Ferrara S.D., Gessa G.L. Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome. Neuropsychopharmacology. 9:1993;77-81.
9. Galloway G.P., Frederick S.L., Staggers F.E. Jr., Gonzales M., Stalcup S.A., Smith D.E. Gamma-hydroxybutyrate. An emerging drug of abuse that causes physical dependence Addiction. 92:1997;89-96.
10. Hechler V., Gobaille S., Bourguignon J.J., Maitre M. Extracellular events induced by γ-hydroxybutyrate in striatum. A microdialysis study J Neurochem. 56:1991;938-944.
11. Hechler V., Gobaille S., Maitre M. Selective distribution pattern of γ-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography. Brain Res. 572:1992;345-348.
12. 1 dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther. 258:1991;882-890.
13. Hurd Y.L., Ungerstedt U. Cocaine. An in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum Synapse. 3:1989;48-54.
14. Jung A.B., Bennett J.P. Jr. Development of striatal dopaminergic function. II. Dopaminergic regulation of transcription of the immediate early gene zif268 and of D1 and D2 receptors during pre- and postnatal development Brain Res Dev Brain Res. 94:1996;121-132.
15. 2 dopamine receptors in rat brain. Brain Res. 532:1990;265-270.
16. Koob G.F. Drugs of abuse. Anatomy, pharmacology, and function of reward pathway Trends Pharmacol Sci. 13:1992;177-184.
17. Kuhar M.J., Pilotte N.S. Neurochemical changes in cocaine withdrawal. Trends Neurosci. 17:1996;260-264.
18. Kuhar M.J., Ritz M.C., Boja J.W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14:1991;299-302.
19. Kunko P.M., French D., Izenwasser S. Alterations in locomotor activity during chronic cocaine administration. Effect on dopamine receptors and interactions with opioids J Pharmacol Exp Ther. 285:1998;277-284.
20. Laborit H. Sodium 4-hydroxybutyrate. Int J Neuropharmacol. 3:1964;433-452.
21. Laurier L.G., Corrigall W.A., George S.R. Dopamine receptor density, sensitivity, and mRNA levels are altered following self-administration of cocaine in the rat. Brain Res. 634:1994;31-40.
22. Le Moine C., Normand E., Guitteny A.F., Fouque B., Teoule R., Bloch B. Dopamine receptor gene expression by enkephalinergic neurons in rat forebrain. Proc Natl Acad Sci USA. 87:1990;230-234.
23. Maitre M. The γ-hydroxybutyrate signaling system in brain. organization and functional implications Prog Neurobiol. 51:1997;337-361.
24. Mamelak M., Scharf M.B., Woods M. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep. 9:1986;285-289.
25. Martellotta M.C., Fattore L., Cossu G., Fratta W. Rewarding properties of gamma-hydroxybutyric acid. An evaluation through place preference paradigm Psychopharmacology. 132:1997;1-5.
26. Martellotta M.C., Balducci C., Fattore L., Cossu G., Gessa G.L., Pulvirenti L., Fratta W. Gamma-hydroxybutyric acid decreases intravenous cocaine self-administration in rats. Pharmacol Biochem Behav. 59:1998;697-702.
27. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd Ed:1986;Academic Press, New South Wales, Australia.
28. Peris J., Boyson S.J., Cass W.A., Curella P., Dwoskin L.P., Larson G., Lin L.H., Yasuda R.P., Zahniser N.R. Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J Pharmacol Exp Ther. 253:1990;38-44.
29. Qin Z.H., Chen J.F., Weiss B. Lesions of the mouse striatum induced by 6-hydroxydopamine differentially alter the density, rate of synthesis, and level of gene expression of D1 and D2 dopamine receptors. J Neurochem. 62:1994;411-420.
30. Roth R.H., Doherty J.D., Walters J.R. Gamma-hydroxybutyrate. A role in the regulation of central dopaminergic neurons? Brain Res. 189:1980;556-560.
31. Roth R.H., Walters J.R., Aghajanian G.K. Effect of impulse flow on the release and synthesis of dopamine in the striatum. Udsin S., Snyder S.H. Frontiers in Catecholamine Research. 1973;567-574 Pergamon Press, New York.
32. Sorg B.A., Guminski B.J.M., Hooks M.S., Kalivas P.W. Cocaine alters glutamic acid decarboxylase differentially in the nucleus accumbens core and shell. Mol Brain Res. 29:1995;381-386.
33. 2 receptor mRNA expression in the olfactory tubercle by cocaine. Mol Brain Res. 19:1993;313-317.
34. Tsukada H., Kreuter J., Maggos C.E., Unterwald E.M., Kakiuchi T., Nishiyama S., Futatsubashi M., Kreek M.J. Effects of binge pattern cocaine administration on dopamine D1 and D2 receptors in the rat brain. an an vivo study using positron emission tomography J Neurosci. 16:1996;7670-7677.
35. Vayer P., Mandel P., Maitre M. Gamma-hydroxybutyrate. A possible neurotransmitter Life Sci. 41:1987;1547-1557.
36. Zhou Q.Y., Grandy D.K., Thambi L., Kushner J.A., Van Tol H.H.M., Cone R., Pribnow D., Salon J., Bunzow J.R., Civelli O. Cloning and expression of human and rat dopamine receptors. Nature. 347:1990;76-80.